Atai Life Sciences’ schizophrenia drug has failed to improve cognition in a phase 2 study, leading the biotech to reaffirm ...

Despite the failure of its Recognify-partnered inidascamine, Jefferies analysts do not expect a definitively negative stock ...

Did you know that patients with post traumatic stress disorder (PTSD) often struggle to forget traumatic memories, even long ...

Excessive levels of GABA released by astrocytes impair the brain's ability to extinguish fear responses in PTSD, but a newly ...

Despite the phase 2b failure of inidascamine for CIAS, I maintain a Buy on Atai due to its diversified psychedelic pipeline.

A new study reveals that astrocytes – support cells in the brain – drive PTSD by releasing excess GABA in the prefrontal ...

Patients with post-traumatic stress disorder (PTSD) often struggle to forget traumatic memories, even long after the danger has passed. This failure to extinguish fear memories has long puzzled ...

A group of scientists led by researchers from the RIKEN Center for Integrative Medical Sciences have discovered that B-cells, a type of immune cell, secrete the neurotransmitter GABA, and also ...

A group of scientists led by researchers from the RIKEN Center for Integrative Medical Sciences have discovered that B-cells, a type of immune cell, secrete the neurotransmitter GABA, and also ...

They found that regulation of the expression of GABA B receptor in astrocytes does not occur in the same way in different brain regions. "This result was totally unexpected," Deneen said.

Study: Neuronal and Non-Neuronal GABA in COVID-19: Relevance for Psychiatry. Image Credit: Explode / Shutterstock Mechanism of senescence in SARS-CoV-2 infection SARS-CoV-2 is a single-stranded ...

Now 500-milligram GABA Supplement with B-6 What you need to know: Now’s GABA and B-6 blend is an affordable supplement that benefits from its two active ingredients’ synergistic properties.